Jove
Visualize
Contact Us

Related Concept Videos

Hepatitis01:25

Hepatitis

63
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
63
Vaccinations01:51

Vaccinations

54.7K
Overview
54.7K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Vaccines01:21

Vaccines

62
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
62
Vaccine Production01:23

Vaccine Production

99
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
99
Cross-reactivity00:42

Cross-reactivity

34.0K
Overview
34.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Projected health benefits and cost offsets from the United States National Hepatitis C Elimination Initiative.

Nature communications·2026
Same author

Towards hepatitis C elimination with integrated risk-based screening and decentralized care in Taiwan.

Nature communications·2026
Same author

Clarification of PSA methods and corrected CEAC for universal HDV testing among adults with chronic HBV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Hepatitis A prevention in the USA depends on routine universal childhood vaccination.

Lancet (London, England)·2026
Same author

Lifetime medical costs of chronic hepatitis C in the United States.

BMC health services research·2026
Same author

Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis.

The International journal on drug policy·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

Making hepatitis E a vaccine-preventable disease.

Eyasu Teshale1, John W Ward

  • 1From the Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta.

The New England Journal of Medicine
|March 5, 2015
PubMed
Summary
This summary is machine-generated.

A new hepatitis E vaccine offers a powerful tool for preventing and controlling hepatitis E virus (HEV) transmission. It can be immediately used to curb HEV outbreaks during humanitarian crises.

More Related Videos

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

7.4K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.3K

Related Experiment Videos

Last Updated: Apr 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

7.4K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.3K

Area of Science:

  • Virology
  • Vaccinology
  • Public Health

Background:

  • Hepatitis E virus (HEV) poses a significant global health threat, causing widespread acute liver inflammation.
  • Outbreaks are common in humanitarian crises due to poor sanitation and contaminated water.

Purpose of the Study:

  • To evaluate the potential of a hepatitis E vaccine as a key intervention strategy.
  • To highlight its immediate application in controlling HEV outbreaks in vulnerable populations.

Main Methods:

  • This study reviews existing data on hepatitis E epidemiology and vaccine efficacy.
  • It analyzes the potential impact of vaccination on disease transmission and outbreak dynamics.

Main Results:

  • A hepatitis E vaccine demonstrates high efficacy in preventing HEV infection and disease.
  • Vaccination can significantly reduce the incidence of hepatitis E, particularly in outbreak settings.

Conclusions:

  • Hepatitis E vaccines represent a crucial advancement in managing HEV.
  • Their deployment, especially during humanitarian emergencies, can be a life-saving public health measure.